Boston Scientific Corporation (BSX) Q3 2026 earnings results
Boston Scientific Corporation (BSX) reported Q3 2026 results on Oct 28, 2026, 6:30:00 AM ET: adjusted EPS $0.73 vs. $0.72 expected (beat by 0.9%); revenue $5.14B vs. $5.05B expected (beat by 1.7%). Outlook: The company estimates fourth quarter 2026 adjusted EPS of $0.77 to $0.79.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $0.73 | $0.72 | Beat by 0.9% |
| Revenue | $5.14B | $5.05B | Beat by 1.7% |
Analyst estimate: the average forecast before the release.
Source
Figures from the press release, released Oct 28, 2026, 6:30:00 AM ET. Nexqual published them 80 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 1.4% from $5.07B.
Stock reaction
The results came out before the market opened. BSX closed at $42.43 on October 28, 2026, down 5.8% from its $45.06 close on October 27, 2026 before the results. Latest: $42.69 (close, October 29, 2026), −5.3% since the pre-release close.
Questions and answers
Did Boston Scientific Corporation beat earnings expectations?
Yes. Boston Scientific Corporation reported adjusted EPS of $0.73 against an average analyst estimate of $0.72 (beat by 0.9%), and revenue of $5.14B against $5.05B expected (beat by 1.7%).
What were Boston Scientific Corporation's Q3 2026 earnings and revenue?
adjusted diluted EPS of $0.73 and revenue of $5.14B. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 1.4% from $5.07B.
When did Boston Scientific Corporation report Q3 2026 earnings?
Oct 28, 2026, 6:30:00 AM ET, in a company press release.
How did BSX stock react to the earnings?
The results came out before the market opened. BSX closed at $42.43 on October 28, 2026, down 5.8% from its $45.06 close on October 27, 2026 before the results. Latest: $42.69 (close, October 29, 2026), −5.3% since the pre-release close.
What did Boston Scientific Corporation say about its outlook?
The company estimates fourth quarter 2026 adjusted EPS of $0.77 to $0.79.
More on BSX
BSX stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings October 28, 2026.
Source: company earnings press release, Nexqual Earnings Flash. Built October 29, 2026 at 23:07 UTC. Not investment advice.
Data source: Nexqual. Last updated: October 29, 2026 at 23:07 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt